Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multi-Modal Deep Learning-Based Model to Predict Burkitt Lymphoma Recurrence.

Avery C Maytin1,2, Jessica A Patricoski-Chavez1,2, Ari Pelcovits3

  • 1Center for Computational Molecular Biology, Brown University, Providence, RI 02912.

AMIA Joint Summits on Translational Science Proceedings. AMIA Joint Summits on Translational Science
|June 19, 2026
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Announcing a New Article Type in <i>JCO Clinical Cancer Informatics</i>: The Resource Report.

JCO clinical cancer informatics·2026
Same author

A randomized controlled study to compare the efficacy of intravitreal faricimab 6.0 mg versus aflibercept 2.0 mg in management of treatment-naive diabetic macular edema in Indian populations.

Indian journal of ophthalmology·2026
Same author

Quantitative fibrinogen disorders: A retrospective study from a tertiary care centre in India.

The Indian journal of medical research·2026
Same author

Ultrawide-field indocyanine angiography changes post 12 weeks of eplerenone in central serous chorioretinopathy.

Indian journal of ophthalmology·2026
Same author

Making LLM Predictions Interpretable: Fine-Tuning GPT-4o for Early Discontinuation of Cancer Medication.

Studies in health technology and informatics·2026
Same author

Therapeutic targeting of RAGE/STAT3 signaling abrogates S100A7-driven breast tumorigenicity and immune suppression.

Breast cancer research : BCR·2026
Same journal

LabSage: Structural-Semantic Decoupling for Enhanced Retrieval-Augmented Generation in Clinical Laboratories.

AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science·2026
Same journal

Evaluating Representation Embeddings from LLMs and Time-Series Foundation Models for Wearable Accelerometer-Based Health Prediction.

AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science·2026
Same journal

ClinNoteAgents: An LLM Multi-Agent System for Predicting and Interpreting Heart Failure 30-Day Readmission from Clinical Notes.

AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science·2026
Same journal

Mapping the Storm: Linking Tornado Paths to Emergency Room Surges Through Geocoded Patient Data.

AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science·2026
Same journal

A Multi-Model LLM Consensus Framework to Identify EHR-Predictable Eligibility Criteria in NSCLC Immunotherapy Trials.

AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science·2026
Same journal

Large Models for Small Tables: Adapting Tabular Foundation Models to EHR Data.

AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science·2026
See all related articles
This summary is machine-generated.

Researchers developed a deep learning model, BLIMP, to predict Burkitt Lymphoma (BL) recurrence using multi-modal data. This model shows promise for improving outcomes in aggressive B-cell non-Hodgkin lymphoma patients.

Area of Science:

  • Oncology
  • Bioinformatics
  • Computational Biology

Background:

  • Burkitt Lymphoma (BL) is an aggressive B-cell non-Hodgkin lymphoma with a poor prognosis for recurrent cases.
  • Currently, there is a lack of predictive models for BL recurrence, despite well-characterized disease pathology.

Purpose of the Study:

  • To develop and evaluate a deep learning model for predicting the recurrence of Burkitt Lymphoma.
  • To assess the model's performance against traditional machine learning approaches.

Main Methods:

  • Developed BLIMP (Burkitt Lymphoma multI-Modal recurrence Predictor), a deep learning model.
  • Integrated clinical, gene expression, and mutation data from 184 patients.
  • Validated the model on a held-out testing set and performed explainability analysis.

Related Experiment Videos

Main Results:

  • The BLIMP model achieved an Area Under the Curve (AUC) of 0.788 on the testing set.
  • Deep learning approach outperformed traditional machine learning models in predicting BL recurrence.
  • Explainability analysis confirmed that predictive features align with known BL pathophysiology.

Conclusions:

  • Deep learning models utilizing genomic data are effective for predicting BL recurrence.
  • BLIMP demonstrates potential for improving recurrence prediction and guiding future research in BL.
  • This approach highlights the utility of multi-modal data integration in cancer recurrence modeling.